Adtec Europe Limited

Adtec Healthcare is delighted to announce that we will start a project to measure the 'Efficacy of non-thermal gas plasma (NTGP) on sub-clinical wound infection (biofilm) in patients with diabetic foot ulcers' in August 2016.

We are delighted to report that Adtec SteriPlas plasma technology has been successfully used to treat surgical site infections.

Adtec Healthcare SteriPlas Wound management technology utilizes gas plasma to reduce the microbial load in wounds regardless of the type or its resistance to antibiotics.

Adtec Healthcare has entered into a licensing and cooperation agreement with the Max Planck Institute for Extraterrestrial Physics and Terraplasma GmbH to exploit a new 6-electrode Plasma generation system.

Adtec Europe Ltd is very pleased to announce CE medical device approval for our MicroPlaSter cold plasma technology and ISO13485 quality certification for the design and manufacture of cold plasma devices.

Come visit the Adtec stand from the 12th to 15th of November 2014 inside the UK pavilion at Medica in Düsseldorf.

Visit us at the 5th International Conference on Plasma Medicine in Nara, Japan from 18 to 23 May 2014.

Adtec Europe’s very own Cold Plasma Device, the PlasmaTact has completed rigorous safety tests and is now CE marked and available to order.

Adtec Europe to develop & launch brand new portable cold plasma device; the PlasmaTact.

MicroPlast Ltd. based in Moscow, Russia will now be able to develop and manufacture Adtec's Plasma Medicine device; the MicroPlaSter.